Assessment of TP53 functionality in chronic lymphocytic leukaemia by different assays; an ERIC-wide approach

ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin

(2013) V. Navrkalova et al.   HAEMATOLOGICA

Functional Analysis of the ATM-p53-p21 Pathway in the LRF CLL4 Trial: Blockade at the Level of p21 Is Associated with Short Response Duration

(2012) K. Lin et al.   CLINICAL CANCER RESEARCH

Biallelic ATM Inactivation Significantly Reduces Survival in Patients Treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 Trial

(2012) Anna Skowronska et al.   JOURNAL OF CLINICAL ONCOLOGY

Functional assessment of p53 in chronic lymphocytic leukemia

(2011) M Le Garff-Tavernier et al.   Blood Cancer Journal

DNA damage-induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing

(2010) J. Mohr et al.   BLOOD

microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia

(2010) D. Asslaber et al.   BLOOD

Monoallelic and biallelic inactivation of TP53 gene in chronic lymphocytic leukemia: selection, impact on survival, and response to DNA damage

(2009) J. Malcikova et al.   BLOOD

Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction

(2009) R Mous et al.   LEUKEMIA

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

(2009) M Mraz et al.   LEUKEMIA